Application of thromboelastography in patients with inflammatory bowel disease or colorectal polyps
-
摘要: 目的 了解炎症性肠病(IBD)和结直肠息肉患者凝血功能的变化规律,探讨血栓弹力图(TEG)在评价两类患者凝血功能中的监测价值。方法 回顾性分析2021年1月—2022年12月在医院就诊的50例IBD患者和85例结直肠息肉患者TEG的凝血反应时间(R)、凝血凝固时间(K)、凝血形成速率(Angle)、凝血最终强度(MA)参数,以139例健康体检者的参数作为对照组,观察各组相关指标的差异。另将患者组的TEG参数与常规凝血指标:凝血酶时间(TT)、活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)、D-二聚体(D-Dimer)、纤维蛋白原(Fib)进行相关性分析。结果 IBD患者与对照组比较,R和K均显著降低;MA显著升高(P<0.05)。在结直肠息肉患者中,R、K和Angle小于对照组;而MA大于对照组,差异有统计学意义(P<0.05)。Spearman相关性分析结果显示,IBD患者的R与APTT、TT呈正相关;K与TT呈正相关,与Fib和D-Dimer呈负相关;Angle与TT、D-Dimer呈负相关, 与Fib呈正相关;而MA与Fib、D-Dimer均呈正相关(P<0.05)。结直肠息肉患者的R与APTT呈显著正相关;K与APTT、TT呈显著正相关;MA与Fib呈显著正相关,均具有线性关系(P<0.05)。结论 TEG在IBD和结直肠息肉患者凝血状态监测中均具有重要的临床意义。TEG和常规凝血功能试验在两类疾病凝血功能评估中可相互补充,不可相互取代。Abstract: Objective To investigate the changes of coagulation function in patients with inflammatory bowel disease(IBD) or colorectal polyps, and evaluate the value of thromboelastography(TEG) in monitoring coagulation function.Methods The parameters of TEG, including reaction time(R), clot kinetics(K), clot strengthening(Angle), maximum amplitude(MA), were retrospectively analyzed in 50 patients with IBD and 85 patients with colorectal polyps treated in hospital from January 2021 to December 2022, and these parameters of 139 healthy subjects were used as the control group. In addition, the correlation between TEG parameters and conventional coagulation indexes, such as thrombin time(TT), activated partial thromboplastin time (APTT), prothrombin time(PT), D-Dimer and fibrinogen (Fib) was analyzed.Results Compared with the control group, the R and K of IBD patients were significantly decreased, MA was significantly increased(P<0.05). In colorectal polyp patients, R, K and Angle were smaller than those in control group, and the MA was higher than that of the control group, with statistical significance(P<0.05). Spearman correlation analysis showed that R was positively correlated with APTT and TT in IBD patients, K was positively correlated with TT, and negatively correlated with Fib and D-Dimer. Angle was negatively correlated with TT and D-Dimer, but positively correlated with Fib. MA was also positively correlated with Fib and D-Dimer(P<0.05). In colorectal polyp patients, there was a significant positive correlation between R and APTT, K was positively correlated with APTT and TT, and there was significant positive correlation between MA and Fib, all had linear relationship(P<0.05).Conclusion TEG may play an important role in monitoring coagulation status in the patients with IBD or colorectal polyps. TEG and conventional coagulation tests can complement each other but not replace each other in the assessment of coagulation function in the two diseases.
-
表 1 3组一般资料比较
组别 例数 性别/例 男/女 年龄/岁 男 女 对照组 139 95 44 2.16 24~81 IBD组 50 33 17 1.94 20~88 结直肠息肉组 85 56 29 1.93 33~64 表 2 TEG参数描述统计
组别 例数 R/min K/min Angle/° MA/mm 对照组 139 6.8(6.1~7.6) 2.2(1.9~2.5) 66.7(63.6~69.0) 58.4(55.8~60.4) IBD组 50 5.7(4.9~6.2)1) 1.5(1.2~1.8)1) 67.7(58.8~72.1) 65.3(60.6~70.2)1) 结直肠息肉组 85 5.2(4.7~6.0)1) 1.7(1.4~2.0)1) 62.5(58.0~68.1)1) 63.7(59.7~67.2)1) 与对照组比较,1)P<0.05。 表 3 IBD患者TEG参数与常规凝血指标相关性分析
参数 R K Angle MA r P r P r P r P PT 0.051 0.725 -0.146 0.311 0.014 0.922 0.085 0.558 APTT 0.358 0.011 0.061 0.675 -0.109 0.452 0.078 0.588 TT 0.399 0.004 0.422 0.002 -0.419 0.002 -0.374 0.007 Fib 0.104 0.471 -0.560 <0.001 0.543 <0.001 0.575 <0.001 D-Dimer -0.137 0.343 -0.507 <0.001 -0.525 <0.001 0.446 0.001 表 4 结直肠息肉患者TEG参数与常规凝血指标相关性分析
参数 R K Angle MA r P r P r P r P PT 0.069 0.529 0.070 0.526 0.132 0.227 -0.033 0.765 APTT 0.357 0.001 0.239 0.027 -0.131 0.232 -0.107 0.332 TT 0.209 0.055 0.238 0.028 0.058 0.600 -0.124 0.259 Fib 0.146 0.186 -0.209 0.057 0.190 0.084 0.253 0.020 D-Dimer -0.011 0.921 -0.084 0.446 -0.260 0.816 0.132 0.229 -
[1] Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management[J]. Gastroenterology, 2022, 162(3): 715-730.e3. doi: 10.1053/j.gastro.2021.10.035
[2] Sullivan BA, Noujaim M, Roper J. Cause, epidemiology, and histology of polyps and pathways to colorectal cancer[J]. Gastrointest Endosc Clin N Am, 2022, 32(2): 177-194. doi: 10.1016/j.giec.2021.12.001
[3] 赵菁, 许波, 赵俊, 等. 陆为民从"心与小肠相表里"论治炎症性肠病[J]. 中国中西医结合消化杂志, 2021, 29(6): 440-444. doi: 10.3969/j.issn.1671-038X.2021.06.12
[4] 孟彤, 陈星, 卢俊会, 等. 普通人群与高危人群结肠息肉检出率的对比研究[J]. 中华胃肠内镜电子杂志, 2020, 7(1): 21-25. doi: 10.3877/cma.j.issn.2095-7157.2020.01.007
[5] Mitrugno A, Tormoen GW, Kuhn P, et al. The prothrombotic activity of cancer cells in the circulation[J]. Blood Rev, 2016, 30(1): 11-19. doi: 10.1016/j.blre.2015.07.001
[6] Mitrugno A, Tassi Yunga S, Sylman JL, et al. The role of coagulation and platelets in colon cancer-associated thrombosis[J]. Am J Physiol Cell Physiol, 2019, 316(2): C264-C273. doi: 10.1152/ajpcell.00367.2018
[7] 茅届齐, 徐多刚, 张米粒, 等. 结肠直肠癌病人D-二聚体升高的研究[J]. 外科理论与实践, 2021, 26(4): 361-366.
[8] Yuhara H, Steinmaus C, Corley D, et al. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease[J]. Aliment Pharmacol Ther, 2013, 37(10): 953-962. doi: 10.1111/apt.12294
[9] Timp JF, Braekkan SK, Versteeg HH, et al. Epidemiology of cancer-associated venous thrombosis[J]. Blood, 2013, 122(10): 1712-1723. doi: 10.1182/blood-2013-04-460121
[10] Ades S, Kumar S, Alam M, et al. Tumor oncogene(KRAS)status and risk of venous thrombosis in patients with metastatic colorectal cancer[J]. J Thromb Haemost, 2015, 13(6): 998-1003. doi: 10.1111/jth.12910
[11] Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease[J]. J Med Life, 2019, 12(2): 113-122. doi: 10.25122/jml-2018-0075
[12] Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis[J]. Surg Clin North Am, 2019, 99(6): 1051-1062. doi: 10.1016/j.suc.2019.08.001
[13] McCurdy JD, Kuenzig ME, Smith G, et al. Risk of venous thromboembolism after hospital discharge in patients with inflammatory bowel disease: a population-based study[J]. Inflamm Bowel Dis, 2020, 26(11): 1761-1768. doi: 10.1093/ibd/izaa002
[14] 王炳予, 袁星星, 刘长发, 等. 解毒化瘀汤治疗活动期溃疡性结肠炎的临床疗效及其对血清细胞因子和凝血指标的影响[J]. 上海中医药大学学报, 2017, 31(4): 32-37.
[15] 周婵, 罗娟, 缪应雷. 炎症性肠病发生静脉血栓的危险因素与治疗进展[J]. 临床内科杂志, 2021, 38(2): 80-83.
[16] 覃弦, 宋军, 侯晓华. 结直肠息肉内镜下诊断及治疗进展[J]. 中华消化内镜杂志, 2021, 38(12): 1040-1046. doi: 10.3760/cma.j.cn321463-20200813-00495
[17] 刘晓辉. 南昌地区结肠癌高危因素与结肠病变的相关性研究[J]. 中国当代医药, 2017, 24(13): 78-80.
[18] 谢媛, 易婉婉, 史秋园, 等. 血栓弹力图和常规凝血试验评估结肠癌和结肠息肉患者凝血状态的临床价值[J]. 检验医学, 2022, 37(11): 1007-1011.
[19] 陈敏, 曾志, 刘建, 等. 血栓弹力图和凝血四项在髋部骨折术后凝血功能中的相关性[J]. 数理医药学杂志, 2023, 36(1): 16-23.
[20] 王建睿, 苗伶俐, 孙海潮, 等. TEG及传统凝血检测指标在孕妇血液不同稀释状态下的相关性探讨[J]. 临床血液学杂志, 2021, 34(4): 284-287. https://lcxy.whuhzzs.com/article/doi/10.13201/j.issn.1004-2806.2021.04.016
[21] 卞良, 单彪, 雷秋香, 等. 血栓弹力图检测结果影响因素及其参数与凝血功能、血小板指标相关性分析[J]. 临床军医杂志, 2023, 51(6): 618-621.
[22] 曹梦霞, 李凤娟, 任璐, 等. 基于血栓弹力图的凝块溶解时间与ACS合并高脂血症患者再发心肌梗死的相关性研究[J]. 临床心血管病杂志, 2022, 38(5): 378-383.
[23] Gopal JP, Dor FJ, Crane JS, et al. Anticoagulation in simultaneous pancreas kidney transplantation-On what basis?[J]. World J Transplant, 2020, 10(7): 206-214. doi: 10.5500/wjt.v10.i7.206
[24] 宋淑莉, 曹倩. 以血栓弹力图为指导预防食管癌患者术后深静脉血栓的护理[J]. 血栓与止血学, 2021, 27(2): 325-326.
[25] 刘嫦钦, 范丽, 邬瑞金, 等. 血栓弹力图对炎症性肠病患者高凝状态的监测价值研究[J]. 国际消化病杂志, 2020, 40(3): 165-170.
[26] 费梦雪. 克罗恩病患者的凝血指标变化研究[D]. 合肥: 安徽医科大学, 2020.
[27] Ramachandran SM, Liu LY, Perkins SH. Peristomal nodule in a patient with ovarian cancer[J]. JAMA, 2018, 319(11): 1158-1159. doi: 10.1001/jama.2018.0770
[28] 董志鹏. 凝血四项、血栓弹力图参数与急性脑梗死患者病情程度的相关性[J]. 中国民康医学, 2023, 35(14): 120-122, 135.
[29] 甘福生, 刘小梅, 郑珣, 等. 围手术期血栓弹力图MA与凝血功能相关性研究[J]. 世界最新医学信息文摘, 2019, 19(84): 225-226.
[30] 潘玲, 刘玲玲, 苏卫东. 常规凝血功能指标与血栓弹力图在患者凝血功能检测中的对比研究[J]. 医学信息, 2022, 35(17): 141-143.